+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients



Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients



Clinical Cancer Research 12(22): 6696-6701



Early breast cancer presents with a remarkable heterogeneity of outcomes. Undetected, microscopic lymph node tumor deposits may account for a significant fraction of this prognostic diversity. Thus, we systematically evaluated the presence of lymph node tumor cell deposits

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048346856

Download citation: RISBibTeXText

PMID: 17121888

DOI: 10.1158/1078-0432.ccr-06-0569


Related references

Axillary lymph node nanometastases are prognostic factors for metastatic relapse in breast cancer patients. Journal of Clinical Oncology 24(18_Suppl): 610-610, 2016

Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European country. World Journal of Surgery 33(8): 1659-1664, 2009

Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis. Isrn Oncology 2011: 645450, 2011

C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer. Cancer 69(12): 2953-2960, 1992

Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients. Plos One 8(4): E61410, 2013

Prognostic factors for relapse in breast cancer patients without axillary node involvement. Bulletin du Cancer 76(2): 181-190, 1989

Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes. Cancer Research and Treatment 2018, 2018

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. American Journal of Surgery 176(6): 502-509, 1999

Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society. Annals of Surgical Oncology 21(4): 1231-1236, 2014

Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery. Zhonghua Zhong Liu Za Zhi 37(1): 41-46, 2015

Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Acta Oncologica 47(2): 232-238, 2007

Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oncology 79(1-2): 105-111, 2011

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Annals of Surgery 240(3): 462-8; Discussion 468-71, 2004

The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection. Annals of Surgery 240(3): 462-471, 2004

Risk Stratification For Axillary Lymph Node Metastases in Breast Cancer Patients: What Clinicopathological and Radiological Factors of Primary Breast Cancer Can Predict Preoperatively Axillary Lymph Node Metastases?. Ultrasound Quarterly 33(1): 15-22, 2016